Viome Life Sciences announced it closed a $86.5 million oversubscribed Series C funding round, bringing its total raise to $175 million. Bold Capital and Khosla Ventures participated in the round alongside existing and new investors.
The…
Funding Intended to Fuel Continued Innovation of RapidAI’s Advanced Clinical Decision and Workflow Support Technology Further Establish a Leadership Position in Clinical AI Solutions
RapidAI, a global leader in developing Artificial Intelligence (AI) and technology…
Stroke is the second leading cause of death globally. About 137,000 people in the U.S. die each year because of stroke — this has created a high demand for technology that facilitates swift and…
Continue Reading
What You Should Know:
– RapidAI, a San Mateo, CA-based digital health company developing artificial intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series…
Continue Reading
DexCare CEO Derek Streat thinks the healthcare industry is at a crossroads. In his view, health systems that are slow to meet patients’ demands for immediate and convenient care access are setting themselves up…
Continue Reading
